Why the study?
Does the use of antiarrhythmic agents or electrical cardioversion reduce 30-day and one-year mortality in patients with atrial fibrillation complicating acute myocardial infarction?
Does the use of antiarrhythmic agents or electrical cardioversion reduce 30-day and one-year mortality in patients with atrial fibrillation complicating acute myocardial infarction?
The use of class I antiarrhythmic agents or sotalol for atrial fibrillation complicating acute myocardial infarction was associated with a trend towards lower mortality, highlighting the need for randomized trials.
No takes yet. Share an insight, caveat, or question.
Class I agents were associated with lower 30-day mortality; hypothesis-generating and requires RCTs before any practice change in post-MI AF.
CK Wong (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: